Margaret Ashton-Key

4PUBLICATIONS
35CO-AUTHORS
Microbial ecologyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 16, 2024
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.

Amatta Mirandari, Helen Parker, Margaret Ashton-Key

|Aug 10, 2022
Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma.

Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf

|Jul 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key

Pageof 1